2296729-00-3
C30H30F2N6O3
560.61
Antineoplastic
Sotorasib
9/15/2040 (Sotorasib)
KRAS
Availability: | |
---|---|
Product Description
Sotorasib is poised to transform cancer treatment by targeting a previously "undruggable" mutation found in numerous solid tumor types. With its selective mechanism of action and potential for improved patient outcomes, Sotorasib holds immense value in the field of precision oncology. Seamlessly incorporate our intermediates into your manufacturing process, ensuring a consistent supply of this exceptional medication. Join us in revolutionizing cancer therapy and making a significant impact on patient lives.
content is empty!